Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group (Q33330595)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group |
scientific article |
Statements
1 reference
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group (English)
1 reference
J J Rusthoven
1 reference
E Eisenhauer
1 reference
C Butts
1 reference
R Gregg
1 reference
J Dancey
1 reference
B Fisher
1 reference
J Iglesias
1 reference
1 April 1999
1 reference
1 reference
17
1 reference
1194
1 reference
Identifiers
1 reference
1 reference